Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: firstname.lastname@example.org. Type 508 Accommodation in the subject line of e-mail.
Update: Influenza Activity --- United States, January 8--14, 2006
During January 8--14, 2006,* the number of states reporting widespread influenza activity increased to eight. Fourteen states reported regional activity, 11 reported local activity, and 16 reported sporadic activity (Figure 1).§
The percentage of specimens testing positive for influenza increased in the United States overall. Since October 2, 2005, the largest numbers of specimens testing positive for influenza have been reported from the Mountain (754 positives) and Pacific (479 positives) regions, accounting for 36.0% and 22.9%, respectively, of positive tests reported during the 2005--06 influenza season. The percentage of outpatient visits for influenza-like illness (ILI)¶ decreased during the week ending January 14 and is below the national baseline.** The percentage of deaths attributed to pneumonia and influenza (P&I) was below the epidemic threshold for the week ending January 14.
During January 8--14, World Health Organization (WHO) collaborating laboratories and National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories in the United States reported testing 2,016 specimens for influenza viruses, of which 238 (11.8%) were positive. Of these, 105 were influenza A (H3N2) viruses, two were influenza A (H1N1) viruses, 125 were influenza A viruses that were not subtyped, and six were influenza B viruses.
Since October 2, 2005, WHO and NREVSS laboratories have tested 43,434 specimens for influenza viruses, of which 2,092 (4.8%) were positive. Of these, 2,026 (96.8%) were influenza A viruses, and 66 (3.2%) were influenza B viruses. Of the 2,026 influenza A viruses, 1,082 (53.4%) have been subtyped; 1,075 (99.4%) were influenza A (H3N2) viruses, and seven (0.6%) were influenza A (H1N1) viruses.
P&I Mortality and ILI Surveillance
During the week ending January 14, P&I accounted for 7.8% of all deaths reported through the 122 Cities Mortality Reporting System. This percentage is below the epidemic threshold of 8.1% (Figure 2).
The percentage of patient visits for ILI was 2.1%, which is below the national baseline of 2.2% (Figure 3). The percentage of patient visits for ILI ranged from 1.1% in the West North Central region to 4.6% in the West South Central region.
Pediatric Deaths and Hospitalizations
During October 2, 2005--January 14, 2006, CDC received reports of 10 influenza-associated deaths in U.S. residents aged <18 years. Eight of the deaths occurred during the current influenza season and two occurred during the 2004--05 influenza season.
During October 1, 2005--January 7, 2006, the preliminary influenza-associated hospitalization rate reported by the Emerging Infections Program§§ (EIP) for children aged 0--17 years was 0.18 per 10,000. For children aged 0--4 years and 5--17 years, the rate was 0.48 per 10,000 and 0.02 per 10,000, respectively. During October 30, 2005--January 7, 2006, the New Vaccine Surveillance Network¶¶ (NVSN) reported no laboratory-confirmed influenza-associated hospitalizations among children aged 0--4 years. EIP and NVSN hospitalization rate estimates are preliminary.
Human Cases of Avian Influenza A (H5N1)
No human case of avian influenza A (H5N1) virus infection has ever been identified in the United States. From December 2003 through January 14, 2006, a total of 151 laboratory-confirmed human cases of avian influenza A (H5N1) infections were reported to WHO from Cambodia, China, Indonesia, Thailand, Turkey, and Viet Nam.*** Of these, 82 (54%) were fatal (Table). This represents an increase of one case and one death in China and two cases and two deaths in Indonesia reported since January 14, 2006. The majority of cases appear to have been acquired from direct contact with infected poultry. No evidence of sustained human-to-human transmission of H5N1 has been detected, although rare cases of human-to-human transmission likely have occurred (1).
* Provisional data reported as of January 20. Additional information about influenza activity is updated each Friday and is available from CDC at http://www.cdc.gov/flu.
Levels of activity are 1) widespread: outbreaks of influenza or increases in influenza-like illness (ILI) cases and recent laboratory-confirmed influenza in at least half the regions of a state; 2) regional: outbreaks of influenza or increases in ILI cases and recent laboratory-confirmed influenza in at least two but less than half the regions of a state; 3) local: outbreaks of influenza or increases in ILI cases and recent laboratory-confirmed influenza in a single region of a state; 4) sporadic: small numbers of laboratory-confirmed influenza cases or a single influenza outbreak reported but no increase in cases of ILI; and 5) no activity.
§ Widespread: Arizona, Colorado, Kansas, Nevada, New Mexico, New York, Texas, and Wyoming; regional: Alaska, California, Connecticut, Georgia, Idaho, Iowa, Kentucky, Mississippi, Oregon, Pennsylvania, Rhode Island, Tennessee, Utah, and Virginia; local: Florida, Indiana, Massachusetts, Minnesota, Montana, Nebraska, North Dakota, Ohio, Oklahoma, Washington, and Wisconsin; sporadic: Alabama, Arkansas, Delaware, Hawaii, Illinois, Louisiana, Maine, Maryland, Michigan, Missouri, New Hampshire, New Jersey, North Carolina, South Dakota, Vermont, and West Virginia; no activity: South Carolina; no report: none.
¶ Temperature of >100.0°F (>37.8°C) and cough and/or sore throat in the absence of a known cause other than influenza.
** The national baseline was calculated as the mean percentage of visits for ILI during noninfluenza weeks for the preceding three seasons, plus two standard deviations. Noninfluenza weeks are those in which <10% of laboratory specimens are positive for influenza. Wide variability in regional data precludes calculating region-specific baselines; therefore, applying the national baseline to regional data is inappropriate.
The expected seasonal baseline proportion of P&I deaths reported by the 122 Cities Mortality Reporting System is projected using a robust regression procedure in which a periodic regression model is applied to the observed percentage of deaths from P&I that occurred during the preceding 5 years. The epidemic threshold is 1.645 standard deviations above the seasonal baseline.
§§ The Emerging Infections Program (EIP) Influenza Project conducts surveillance in 60 counties associated with 12 metropolitan areas: San Francisco, California; Denver, Colorado; New Haven, Connecticut; Atlanta, Georgia; Baltimore, Maryland; Minneapolis/St. Paul, Minnesota; Albuquerque, New Mexico; Las Cruces, New Mexico; Albany, New York; Rochester, New York; Portland, Oregon; and Nashville, Tennessee.
¶¶ The New Vaccine Surveillance Network (NVSN) conducts surveillance in Monroe County, New York; Hamilton County, Ohio; and Davidson County, Tennessee.
*** Available at http://www.who.int/csr/disease/avian_influenza/en.
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.**Questions or messages regarding errors in formatting should be addressed to email@example.com.
Date last reviewed: 1/26/2006